NovoCure Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Silverback Therapeutics.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Silverback Therapeutics
Silverback Therapeutics
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
Founding Date
Founding Date
2018
Founding Date
2016
Type
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Seattle, US HQ
Employees
Employees
188
Employees
9067% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
550.4 m

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$1.3m (FY, 2022)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($34.7m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Silverback Therapeutics
HQ
Seattle, US
Employees
90

Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.

View company